United States Drug Screening Market Report 2018

March 2018 | 100 pages | ID: U4CCFF97FC9EN
QYResearch

Abstracts

In this report, the United States Drug Screening market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Drug Screening in these regions, from 2013 to 2025 (forecast).

United States Drug Screening market competition by top manufacturers/players, with Drug Screening sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alere
• Express Diagnostics
• Laboratory Corporation of America
• MPD
• Quest Diagnostics
• Roche Diagnostics
• Shimadzu
• Siemens Healthcare
• Thermo Fisher Scientific

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Immunoassay Analyzers
• Chromatography
• Breath Analyzers
• Rapid Testing Devices
• Assay Kits and Reagents

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Research Institute
• Biotechnology & Pharmaceutical Companies
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Drug Screening Market Report 2018

1 DRUG SCREENING OVERVIEW

1.1 Product Overview and Scope of Drug Screening
1.2 Classification of Drug Screening by Product Category
  1.2.1 United States Drug Screening Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Drug Screening Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Immunoassay Analyzers
  1.2.4 Chromatography
  1.2.5 Breath Analyzers
  1.2.6 Rapid Testing Devices
  1.2.7 Assay Kits and Reagents
1.3 United States Drug Screening Market by Application/End Users
  1.3.1 United States Drug Screening Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Research Institute
  1.3.4 Biotechnology & Pharmaceutical Companies
  1.3.5 Other
1.4 United States Drug Screening Market by Region
  1.4.1 United States Drug Screening Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Drug Screening Status and Prospect (2013-2025)
  1.4.3 Southwest Drug Screening Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Drug Screening Status and Prospect (2013-2025)
  1.4.5 New England Drug Screening Status and Prospect (2013-2025)
  1.4.6 The South Drug Screening Status and Prospect (2013-2025)
  1.4.7 The Midwest Drug Screening Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Drug Screening (2013-2025)
  1.5.1 United States Drug Screening Sales and Growth Rate (2013-2025)
  1.5.2 United States Drug Screening Revenue and Growth Rate (2013-2025)

2 UNITED STATES DRUG SCREENING MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Drug Screening Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Drug Screening Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Drug Screening Average Price by Players/Suppliers (2013-2018)
2.4 United States Drug Screening Market Competitive Situation and Trends
  2.4.1 United States Drug Screening Market Concentration Rate
  2.4.2 United States Drug Screening Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drug Screening Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DRUG SCREENING SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Drug Screening Sales and Market Share by Region (2013-2018)
3.2 United States Drug Screening Revenue and Market Share by Region (2013-2018)
3.3 United States Drug Screening Price by Region (2013-2018)

4 UNITED STATES DRUG SCREENING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Drug Screening Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Drug Screening Revenue and Market Share by Type (2013-2018)
4.3 United States Drug Screening Price by Type (2013-2018)
4.4 United States Drug Screening Sales Growth Rate by Type (2013-2018)

5 UNITED STATES DRUG SCREENING SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Drug Screening Sales and Market Share by Application (2013-2018)
5.2 United States Drug Screening Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES DRUG SCREENING PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alere
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drug Screening Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alere Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Express Diagnostics
  6.2.2 Drug Screening Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Express Diagnostics Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Laboratory Corporation of America
  6.3.2 Drug Screening Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Laboratory Corporation of America Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 MPD
  6.4.2 Drug Screening Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 MPD Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Quest Diagnostics
  6.5.2 Drug Screening Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Quest Diagnostics Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Roche Diagnostics
  6.6.2 Drug Screening Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Diagnostics Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Shimadzu
  6.7.2 Drug Screening Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shimadzu Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Siemens Healthcare
  6.8.2 Drug Screening Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Siemens Healthcare Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Thermo Fisher Scientific
  6.9.2 Drug Screening Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Thermo Fisher Scientific Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 DRUG SCREENING MANUFACTURING COST ANALYSIS

7.1 Drug Screening Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug Screening

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drug Screening Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug Screening Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DRUG SCREENING MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Drug Screening Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Drug Screening Sales Volume Forecast by Type (2018-2025)
11.3 United States Drug Screening Sales Volume Forecast by Application (2018-2025)
11.4 United States Drug Screening Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drug Screening
Figure United States Drug Screening Market Size (K Units) by Type (2013-2025)
Figure United States Drug Screening Sales Volume Market Share by Type (Product Category) in 2017
Figure Immunoassay Analyzers Product Picture
Figure Chromatography Product Picture
Figure Breath Analyzers Product Picture
Figure Rapid Testing Devices Product Picture
Figure Assay Kits and Reagents Product Picture
Figure United States Drug Screening Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Drug Screening by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Research Institute Examples
Table Key Downstream Customer in Research Institute
Figure Biotechnology & Pharmaceutical Companies Examples
Table Key Downstream Customer in Biotechnology & Pharmaceutical Companies
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Drug Screening Market Size (Million USD) by Region (2013-2025)
Figure The West Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Drug Screening Sales (K Units) and Growth Rate (2013-2025)
Figure United States Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Drug Screening Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Drug Screening Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Drug Screening Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Drug Screening Sales Share by Players/Suppliers
Figure 2017 United States Drug Screening Sales Share by Players/Suppliers
Figure United States Drug Screening Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Drug Screening Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Drug Screening Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Drug Screening Revenue Share by Players/Suppliers
Figure 2017 United States Drug Screening Revenue Share by Players/Suppliers
Table United States Market Drug Screening Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Drug Screening Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Drug Screening Market Share of Top 3 Players/Suppliers
Figure United States Drug Screening Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drug Screening Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drug Screening Product Category
Table United States Drug Screening Sales (K Units) by Region (2013-2018)
Table United States Drug Screening Sales Share by Region (2013-2018)
Figure United States Drug Screening Sales Share by Region (2013-2018)
Figure United States Drug Screening Sales Market Share by Region in 2017
Table United States Drug Screening Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Drug Screening Revenue Share by Region (2013-2018)
Figure United States Drug Screening Revenue Market Share by Region (2013-2018)
Figure United States Drug Screening Revenue Market Share by Region in 2017
Table United States Drug Screening Price (USD/Unit) by Region (2013-2018)
Table United States Drug Screening Sales (K Units) by Type (2013-2018)
Table United States Drug Screening Sales Share by Type (2013-2018)
Figure United States Drug Screening Sales Share by Type (2013-2018)
Figure United States Drug Screening Sales Market Share by Type in 2017
Table United States Drug Screening Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Drug Screening Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Drug Screening by Type (2013-2018)
Figure Revenue Market Share of Drug Screening by Type in 2017
Table United States Drug Screening Price (USD/Unit) by Types (2013-2018)
Figure United States Drug Screening Sales Growth Rate by Type (2013-2018)
Table United States Drug Screening Sales (K Units) by Application (2013-2018)
Table United States Drug Screening Sales Market Share by Application (2013-2018)
Figure United States Drug Screening Sales Market Share by Application (2013-2018)
Figure United States Drug Screening Sales Market Share by Application in 2017
Table United States Drug Screening Sales Growth Rate by Application (2013-2018)
Figure United States Drug Screening Sales Growth Rate by Application (2013-2018)
Table Alere Basic Information List
Table Alere Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alere Drug Screening Sales Growth Rate (2013-2018)
Figure Alere Drug Screening Sales Market Share in United States (2013-2018)
Figure Alere Drug Screening Revenue Market Share in United States (2013-2018)
Table Express Diagnostics Basic Information List
Table Express Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Express Diagnostics Drug Screening Sales Growth Rate (2013-2018)
Figure Express Diagnostics Drug Screening Sales Market Share in United States (2013-2018)
Figure Express Diagnostics Drug Screening Revenue Market Share in United States (2013-2018)
Table Laboratory Corporation of America Basic Information List
Table Laboratory Corporation of America Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Laboratory Corporation of America Drug Screening Sales Growth Rate (2013-2018)
Figure Laboratory Corporation of America Drug Screening Sales Market Share in United States (2013-2018)
Figure Laboratory Corporation of America Drug Screening Revenue Market Share in United States (2013-2018)
Table MPD Basic Information List
Table MPD Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MPD Drug Screening Sales Growth Rate (2013-2018)
Figure MPD Drug Screening Sales Market Share in United States (2013-2018)
Figure MPD Drug Screening Revenue Market Share in United States (2013-2018)
Table Quest Diagnostics Basic Information List
Table Quest Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Quest Diagnostics Drug Screening Sales Growth Rate (2013-2018)
Figure Quest Diagnostics Drug Screening Sales Market Share in United States (2013-2018)
Figure Quest Diagnostics Drug Screening Revenue Market Share in United States (2013-2018)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Diagnostics Drug Screening Sales Growth Rate (2013-2018)
Figure Roche Diagnostics Drug Screening Sales Market Share in United States (2013-2018)
Figure Roche Diagnostics Drug Screening Revenue Market Share in United States (2013-2018)
Table Shimadzu Basic Information List
Table Shimadzu Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shimadzu Drug Screening Sales Growth Rate (2013-2018)
Figure Shimadzu Drug Screening Sales Market Share in United States (2013-2018)
Figure Shimadzu Drug Screening Revenue Market Share in United States (2013-2018)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Siemens Healthcare Drug Screening Sales Growth Rate (2013-2018)
Figure Siemens Healthcare Drug Screening Sales Market Share in United States (2013-2018)
Figure Siemens Healthcare Drug Screening Revenue Market Share in United States (2013-2018)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Thermo Fisher Scientific Drug Screening Sales Growth Rate (2013-2018)
Figure Thermo Fisher Scientific Drug Screening Sales Market Share in United States (2013-2018)
Figure Thermo Fisher Scientific Drug Screening Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug Screening
Figure Manufacturing Process Analysis of Drug Screening
Figure Drug Screening Industrial Chain Analysis
Table Raw Materials Sources of Drug Screening Major Players/Suppliers in 2017
Table Major Buyers of Drug Screening
Table Distributors/Traders List
Figure United States Drug Screening Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Drug Screening Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Drug Screening Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Drug Screening Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Drug Screening Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Drug Screening Sales Volume (K Units) Forecast by Type in 2025
Table United States Drug Screening Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Drug Screening Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Drug Screening Sales Volume (K Units) Forecast by Application in 2025
Table United States Drug Screening Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Drug Screening Sales Volume Share Forecast by Region (2018-2025)
Figure United States Drug Screening Sales Volume Share Forecast by Region (2018-2025)
Figure United States Drug Screening Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources